Alto Neuroscience · 1 week ago
Head of Patient Recruitment & Engagement
Alto Neuroscience is seeking a Head of Patient Recruitment & Engagement to lead their global recruitment and engagement strategy across clinical development programs. This role focuses on designing a data-driven, patient-centric recruitment model to enhance study enrollment and participant experience.
Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Responsibilities
Develop and implement a comprehensive recruitment and engagement strategy aligned with corporate and program objectives
Build robust analytics frameworks to measure and optimize recruitment funnel performance
Lead cross-functional collaboration with Clinical Operations, Data Science, and external partners to ensure seamless execution
Drive patient engagement initiatives through strategic partnerships with advocacy groups and community organizations
Champion diversity, equity, and inclusion across all recruitment activities
Build, lead, and mentor a high-performing recruitment and engagement team
Qualification
Required
10+ years of experience in patient recruitment, clinical operations, or related functions, including 5+ years in a senior leadership capacity within biotech, pharma, or CRO settings
Demonstrated success achieving or exceeding enrollment goals using analytics-driven methodologies
Deep understanding of digital recruitment platforms, CRM systems, and data visualization tools
Strong strategic, analytical, and executive communication skills
Bachelor's degree required
Preferred
advanced degree (MS, MPH, MBA, or equivalent)
Benefits
Compensation includes a base salary, an annual target bonus, and an equity grant.
Company
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Funding
Current Stage
Public CompanyTotal Funding
$300.96MKey Investors
Perceptive AdvisorsWellcome TrustInVivium Capital
2025-10-20Post Ipo Equity· $50M
2024-07-25Grant· $11.7M
2024-02-02IPO
Recent News
2026-01-16
Company data provided by crunchbase